An expert discusses how rilzabrutinib’s oral administration and broad tolerability make it a practical treatment option while ...
An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains ...
HemostOD, a private Swiss company pioneering the ex vivo manufacturing of donor-free, off-the-shelf universal human blood platelets, today announced the successful closing of a CHF 4.3 million ...
Since 2010, September has been recognized as Blood Cancer Awareness Month, bringing attention to leukemia, lymphoma, myeloma and other cancers targeting the blood. A challenge faced by many battling ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback